Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 4

The association between visceral adiposity index levels and the change of the glomerular filtration rate in patients with chronic kidney disease

Pages
1428–1432
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Developed to indicate the metabolic effect of VAT, VAI has shown no association with the one-year decrease of eGFR in those with CKD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity is an expanding health challenge due to its increasing prevalence across the world.
📊
Key Findings & Data:Previous studies demonstrated that the prevalence of VAI was associated with CKD.
💡
Conclusion & Impact:Developed to indicate the metabolic effect of VAT, VAI has shown no association with the one-year decrease of eGFR in those with CKD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity is an expanding health challenge due to its increasing prevalence across the world. Obesity is associated with chronic kidney disease (CKD) with the advancement of diabetes mellitus (DM) and hypertension (HT), causing CKD by affecting the kidneys directly. The visceral adiposity index (VAI) has recently been developed to assess the metabolic function of visceral adipose tissue (VAT). Previous studies demonstrated that the prevalence of VAI was associated with CKD. The present study aimed to investigate the association between the decline of estimated glomerular filtration rate (eGFR) and VAT. Followed in the Nephrology Department of Research and Training Hospital for one year, 129 patients aged between 18-80 years with stages 2-5 CKD and not on dialysis were enrolled into the study. Sixty-three (40.6%) patients were females, and the mean age was 66.8 years. The averages of decreased eGFR and VAI values were also found as 12.8±19.0 mL/min/1.73 m2 and 2.86±1.63, respectively. The values of VAI were not correlated with the decrease in eGFR. The VAI values (p=0.03) and eGFR decrease (p=0.04) were higher in those with DM. Developed to indicate the metabolic effect of VAT, VAI has shown no association with the one-year decrease of eGFR in those with CKD.

🔖

Cite This Article

Adibelli, Z. (2022). The association between visceral adiposity index levels and the change of the glomerular filtration rate in patients with chronic kidney disease. Medicine Science, Cilt: 10 - Sayı: 4, 1428–1432. https://ajindex.com/articles/579709

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Flegal KM, Kruszon-Moran D, Carroll MD,et al. Trends in obesity among adults in the united states, 2005 to 2014. JAMA. 2016;7;315:2284-91
  2. Hruby A, Hu FB. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2015;33:673-89
  3. Ural D, Kılıçkap M, Göksülük H, et al. Data on prevalence of obesity and waist circumference in Turkey: Systematic review, meta-analysis, and meta-regression of epidemiological studies on cardiovascular risk factors. Turk Kardiyol Dern Ars. 2018;46:577-90
  4. Ruan, X.Z., Z. Varghese, and J.F. Moorhead, An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol, 2009. 5:713-21
  5. Ruster, C. and G. Wolf, The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol, 2013.33:44-53
  6. Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis. 2005;46:587-94
  7. Wang, H., Y.E. Chen, and D.T. Eitzman, Imaging body fat: techniques and cardiometabolic implications. Arterioscler Thromb Vasc Biol, 2014. 34: 2217-23
  8. Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014:730827
  9. Xu X, Zhao Y, Zhao Z, et al. Correlation of visceral adiposity index with chronic kidney disease in the People's Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity. Ther Clin Risk Manag. 2016,29;12:489-94
  10. Huang J, Zhou C, Li Y, et al. Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study. Int Urol Nephrol. 2015;47:1387-96
  11. Dai D, Chang Y, Chen Y, et al. Visceral Adiposity Index, and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China. Int J Environ Res Public Health. 2016;13:1231
  12. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870-6
  13. Lew QJ, Jafar TH, Talaei M, et al. Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. Kidney Int. 2017;92:979-987
  14. Lu JL, Kalantar-Zadeh K, Ma JZ, et al. Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol. 2014;25:2088-96
  15. Kramer H, Gutiérrez OM, Judd SE, et al. Waist Circumference